VenoStent Technology Receives Breakthrough Device Designation by FDA
Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular
Source: finanznachrichten.de